May 16, 2008
I lean toward "Bust"
Analysis of:
Analyst: $850M opportunity for Allscripts with merger | www.forbes.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Implications: Difficulty in turning the potential opportunity into sales
Analysis: I'm inclined to agree with the JP Morgan analyst in the thought that the new company will not capture a significant portion of the EMR business represented by the installed base of Misys' Practice Management.
There is thought that Misys customers will adopt AllScripts' TouchWorks EMR at the same rate IDX customers did. Likely not the case considering the somewhat luke warm customer satisfaction of Misys customers compared to IDX and the recent painful news regarding TouchWorks v11 upgrades and new installs.
Analysis: I'm inclined to agree with the JP Morgan analyst in the thought that the new company will not capture a significant portion of the EMR business represented by the installed base of Misys' Practice Management.
There is thought that Misys customers will adopt AllScripts' TouchWorks EMR at the same rate IDX customers did. Likely not the case considering the somewhat luke warm customer satisfaction of Misys customers compared to IDX and the recent painful news regarding TouchWorks v11 upgrades and new installs.
Report a Concern
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Use of Antipsychotics in Children Is Criticized
www.nytimes.com
Scientists recommend 'black box' for Avastin
www.fiercepharma.com
Are Costly Diabetes Pills Doing Any Good?
www.pharmalot.com
How a Drug Maker Tries to Outwit Generics
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

